Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Niki D.J. Ubags, Miguel A. Alejandre Alcazar, Suhas G. Kallapur, Sylvia Knapp, Sophie Lanone, Clare M. Lloyd, Rory E. Morty, Céline Pattaroni, Niki L. Reynaert, Robbert J. Rottier, Hermelijn H. Smits, Wouter A.A. de Steenhuijsen Piters, Deborah H. Strickland, Jennifer J.P. Collins. Early origins of lung disease: towards an interdisciplinary approach. Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020

Member's Comments

No comment yet.

Related content which might interest you: A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease Source: Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021 Year: 2021 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 The characterisation of interstitial lung disease multidisciplinary team meetings: a global study Source: ERJ Open Res, 5 (2) 00209-2018; 10.1183/23120541.00209-2018 Year: 2019 Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005 Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019 Treatment of limited disease small cell lung cancer: the multidisciplinary team Source: Eur Respir J, 50 (2) 1700422; 10.1183/13993003.00422-2017 Year: 2017 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 The effectiveness of a multidisciplinary approach in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Contemporary challenges for specialist nursing in interstitial lung disease Source: Breathe, 14 (1) 36; 10.1183/20734735.014917 Year: 2018 Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Early origins of chronic pulmonary disease: the role of the adult pulmonologist Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020 Development of a pulmonary nodule service & clinical pathway: A pragmatic approach addressing an unmet need Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Treatment of early lung disease – is it possible? Does it work? Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004 New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012 Management of early stage lung cancer: a surgeon's perspective Source: Eur Respir Monogr 2015; 68: 136-147 Year: 2015